Skip to main content
. 2017 Oct 26;12(12):2024–2031. doi: 10.2215/CJN.06100617

Table 3.

Subgroup analyses: Adjusted risk of death in transplant recipients compared with patients who remained on dialysis

Subgroup Hazard Ratio for Transplant within Subgroup (95% CI)
All patients 0.60 (0.53 to 0.68)
Age, yr
 <40 0.44 (0.32 to 0.61)
 40–49 0.49 (0.38 to 0.63)
 50–59 0.49 (0.39 to 0.61)
 60–64 0.52 (0.38 to 0.70)
 65–69 0.60 (0.40 to 0.91)
Women 0.38 (0.31 to 0.46)
Men 0.58 (0.50 to 0.68)
Race
 White non-Hispanic 0.51 (0.39 to 0.67)
 White Hispanic 0.46 (0.34 to 0.62)
 Black 0.46 (0.34 to 0.63)
Diabetes as cause of kidney failure 0.73 (0.58 to 0.93)
Other causes 0.56 (0.49 to 0.65)
Panel reactive antibody, %
 0 0.61 (0.49 to 0.75)
 1–79 0.60 (0.49 to 0.72)
 80–89 0.74 (0.42 to 1.32)
 90–98 0.96 (0.60 to 1.52)
 99–100 0.60 (0.53 to 0.68)
Expected post-transplant survival, %
 1–20 0.49 (0.35 to 0.67)
 21–40 0.51 (0.39 to 0.65)
 41–60 0.69 (0.53 to 0.90)
 61–80 0.60 (0.46 to 0.78)
 81–100 0.75 (0.58 to 0.97)

Multivariate model adjusted for differences in patient age, sex, race, cause of kidney disease, body mass index in kilograms per meter2, comorbid conditions, sensitization, and year of first chronic dialysis treatment. 95% CI, 95% confidence interval.